About Chvng - Unidade I
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Associacao de Investigacao de Cuidados de Suporte em Oncologia
2
Abbott Medical Devices
1
Daiichi Sankyo, Inc.
1
EMD Serono Research & Development Institute, Inc.
1
Clinical Trials at Chvng - Unidade I
During the past decade, Chvng - Unidade I conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
2020-08-07
2027-04-30
Active, not recruiting
730
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated With the Abbott TriClip™ Device (bRIGHT)
2020-08-27
2028-01-01
Active, not recruiting
501
Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based
2021-05-01
2021-09-30
Completed
12
A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease
2022-01-19
2025-08-14
Recruiting
318
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
2022-07-22
2030-10-08
Recruiting
715
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
2022-09-19
2030-09-27
Recruiting
550
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
2022-05-10
2026-08-04
Recruiting
560
Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial
2021-06-01
2024-05-30
Recruiting
46
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chvng - Unidade I" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Associacao de Investigacao de Cuidados de Suporte em Oncologia" with 2 trials
sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chvng - Unidade I"
#1 collaborator was "Centro Hospitalar de Vila Nova de Gaia/Espinho" with 2 trials as a collaborator, "University Institute of Maia" with 2 trials as a collaborator, "Aveiro University" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Chvng - Unidade I
According to Clinical.Site data, the most researched conditions in "Chvng - Unidade I" are
"Breast Cancer" (1 trials), "Colitis, Ulcerative" (1 trials), "Crohn Disease" (1 trials), "Crohn's Disease" (1 trials) and "EGFR Exon 19 Deletion" (1 trials). Many other conditions were trialed in "Chvng - Unidade I" in a lesser frequency.
Clinical Trials Intervention Types at Chvng - Unidade I
Most popular intervention types in "Chvng - Unidade I" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Cisplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chvng - Unidade I
The vast majority of trials in "Chvng - Unidade I" are
7 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Chvng - Unidade I
Currently, there are NaN active trials in "Chvng - Unidade I".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Chvng - Unidade I,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chvng - Unidade I, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".